Compare Lustrum:NANO MRNA Co., Ltd.:4571

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index NANO MRNA Co., Ltd. Go to web site 4571 Medicals 東証グロース March 1, 2000 2008.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

NANO MRNA Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

NANO MRNA Co., Ltd. Balance Sheet 2023年3月期 NANO MRNA Co., Ltd. Balance Sheet 2022年3月期 NANO MRNA Co., Ltd. Balance Sheet 2021年3月期 NANO MRNA Co., Ltd. Balance Sheet 2020年3月期 NANO MRNA Co., Ltd. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents
(Percent)
2,812down
(48.6%)down
3,545down
(49.7%)down
3,892down
(49.8%)down
4,471down
(50.0%)down
4,567
(53.3%)
Other Current AssetsHelp
(Percent)
1,857down
(32.1%)down
2,759down
(38.7%)up
3,010down
(38.5%)down
3,449up
(38.6%)up
2,419
(28.2%)
Tangible Fixed AssetsHelp
(Percent)
0
-
7up
(0.1%)up
4up
(0.1%)up
0down
(0.0%)down
3
(0.0%)
Intangible Fixed AssetHelp
(Percent)
0
(0.0%)up
0down
(0.0%)down
13up
(0.2%)up
0down
(0.0%)down
2
(0.0%)
Investments and OthersHelp
(Percent)
1,115up
(19.3%)up
825down
(11.6%)up
901down
(11.5%)up
1,024down
(11.5%)down
1,577
(18.4%)
Total AssetsHelp
(Percent)
5,784
(100%)
7,136
(100%)
7,821
(100%)
8,945
(100%)
8,568
(100%)
Total Current LiabilitiesHelp
(Percent)
422up
(7.3%)up
419up
(5.9%)up
321up
(4.1%)up
176down
(2.0%)down
214
(2.5%)
Total Long-term LiabilitiesHelp
(Percent)
1,109down
(19.2%)up
1,150
(16.1%)
0
-
0
-
2,475
(28.9%)
Shareholder's EquityHelp
(Percent)
4,253down
(73.5%)down
5,567down
(78.0%)down
7,500down
(95.9%)down
8,769up
(98.0%)up
5,880
(68.6%)
Total LiabilitiesHelp
(Percent)
5,784
(100%)
7,136
(100%)
7,821
(100%)
8,945
(100%)
8,568
(100%)

NANO MRNA Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

NANO MRNA Co., Ltd. Profit and Loss Account 2023年3月期 NANO MRNA Co., Ltd. Profit and Loss Account 2022年3月期 NANO MRNA Co., Ltd. Profit and Loss Account 2021年3月期 NANO MRNA Co., Ltd. Profit and Loss Account 2020年3月期 NANO MRNA Co., Ltd. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales
(Percent)
202
(100%)
264
(100%)
313
(100%)
553
(100%)
497
(100%)
Total Sales
(Percent)
202
(100%)
264
(100%)
313
(100%)
553
(100%)
497
(100%)
Cost of SalesHelp
(Percent)
43up
(21.1%)up
41up
(15.6%)up
38down
(12.2%)down
78down
(14.1%)down
80
(16.1%)
Other Costs and RevenueHelp 1,471down
(727.3%)down
2,104down
(797.0%)down
3,111up
(993.0%)up
2,485up
(449.3%)up
2,225
(448.0%)
Total CostsHelp 1,513 2,146 3,149 2,563 2,305
Net RevenueHelp 160down
(78.9%)down
223down
(84.4%)down
275down
(87.8%)up
475up
(85.9%)up
417
(83.9%)
Earnings Before TaxHelp -1,308up
(-647.2%)up
-1,879up
(-711.7%)up
-2,832down
(-904.0%)down
-2,006down
(-362.8%)up
-1,805
(-363.4%)
Net IncomeHelp -1,311up
(-648.4%)up
-1,882up
(-712.7%)up
-2,836down
(-905.2%)down
-2,010down
(-363.4%)up
-1,809
(-364.1%)
当期純利益 -1,311 -1,882 -2,836 -2,010 -1,809

NANO MRNA Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

NANO MRNA Co., Ltd. Cash Flow Statement 2023年3月期 NANO MRNA Co., Ltd. Cash Flow Statement 2022年3月期 NANO MRNA Co., Ltd. Cash Flow Statement 2021年3月期 NANO MRNA Co., Ltd. Cash Flow Statement 2020年3月期 NANO MRNA Co., Ltd. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
-1,055up
(-85.2%)up
-1,753down
(-87.8%)down
-1,200down
(-57.6%)down
-1,139up
(-52.7%)up
-2,037
(-59.8%)
Investing Cash Flow(ICF)Help
(Percent)
1,208up
(97.6%)up
-244up
(-12.2%)up
-872down
(-41.8%)down
-112up
(-5.2%)up
-992
(-29.1%)
Financing Cash FlowHelp
(Percent)

-
1,146up
(57.4%)up
-11down
(-0.6%)down
2,162down
(100.0%)up
3,385
(99.4%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)

-
57up
(2.8%)up
5up
(0.2%)up
-5down
(-0.2%)down
22
(0.6%)
Net Increase and Decrease in Cash and Cash Equivalentsn 213up
(17.2%)up
-795up
(-39.8%)up
-2,079down
(-99.8%)down
905up
(41.9%)up
377
(11.1%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

NANO MRNA Co., Ltd.

Company where related level is highHelp

HISAMITSU PHARMACEUTICAL CO.,INC.
Noile-Immune Biotech Inc.
KYORIN Pharmaceutical Co., Ltd.
SANTEN PHARMACEUTICAL CO.,LTD.
ZERIA PHARMACEUTICAL CO.,LTD.
KAKEN PHARMACEUTICAL CO.,LTD.
MORISHITA JINTAN CO.,LTD.
ONO PHARMACEUTICAL CO.,LTD.
Nissui Pharmaceutical Co.,Ltd.
Solasia Pharma K.K.